Download PDF
Thromb Haemost 2002; 88(01): 165-166
DOI: 10.1055/s-0037-1613175
Letters to the Editor
Schattauer GmbH

Endocannabinoids: New Physiological (Co-)Agonists of Human Platelets

Mauro Maccarrone
1   Departments of Experimental Medicine and Biochemical Sciences, Rome, Italy
,
Domenico Del Principe
1   Public Health and Cell Biology, University of Rome Tor Vergata, Rome, Italy
,
Alessandro Finazzi-Agrò
1   Departments of Experimental Medicine and Biochemical Sciences, Rome, Italy
› Author Affiliations
Further Information

Publication History

Received 22 February 2002

Accepted 24 February 2002

Publication Date:
09 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Fox JE. Cytoskeletal proteins and platelet signaling. Thromb Haemost 2001; 86: 198-213.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Furie B, Furie BC, Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001; 86: 214-21.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Phillips DR, Nannizzi-Alaimo L, Prasad KS. Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb Haemost 2001; 86: 246-58.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Howlett AC, Mukhopadhyay S. Cellular signal transduction by anandamide and 2-arachidonoylglycerol. Chem Phys Lipids 2000; 108: 53-70.
    CrossrefPubMedGoogle Scholar
  • 5 Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE. et al. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci USA 2001; 98: 3662-5.
    CrossrefPubMedGoogle Scholar
  • 6 Kunos G, Jarai Z, Batkai S, Goparaju SK, Ishac EJ, Liu J. et al. Endocan nabinoids as cardiovascular modulators. Chem Phys Lipids 2000; 108: 159-68.
    CrossrefPubMedGoogle Scholar
  • 7 Maccarrone M, Bari M, Battista N, Finazzi-Agrò A. Endocannabinoid degradation, endotoxic shock and inflammation. Current Drug Targets -Inflammation & Allergy 2002; 02: 53-63.
    PubMedGoogle Scholar
  • 8 Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J. et al. Endo cannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nature Med 2001; 07: 827-32.
    CrossrefPubMedGoogle Scholar
  • 9 Maccarrone M, Bari M, Menichelli A, Giuliani E, Del Principe D, Finazzi-Agrò A. Human platelets bind and degrade 2-arachidonoylglycerol, which activates these cells through a cannabinoid receptor. Eur J Biochem 2001; 268: 819-25.
    CrossrefPubMedGoogle Scholar
  • 10 Daniel JL, Dangelmaier C, Jin J, Ashby B, Smith JB, Kunapuli SP. Molecular basis for ADP-induced platelet activation. I. Evidence for three distinct ADP receptors on human platelets. J Biol Chem 1998; 273: 2024-9.
    CrossrefPubMedGoogle Scholar
  • 11 Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S. et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-4.
    CrossrefPubMedGoogle Scholar
  • 12 Braud S, Bon C, Touqui L, Mounier C. Activation of rabbit blood platelets by anandamide through its cleavage into arachidonic acid. FEBS Lett 2000; 471: 12-6.
    CrossrefPubMedGoogle Scholar
  • 13 Maccarrone M, Finazzi-Agro A. Platelet activation: a new vascular activity of anandamide. FEBS Lett 2000; 483: 84-5.
    PubMedGoogle Scholar
  • 14 Maccarrone M, De Petrocellis L, Bari M, Fezza F, Salvati S, Di Marzo V. et al. Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes. Arch Biochem Biophys 2001; 393: 321-28.
    CrossrefPubMedGoogle Scholar
  • 15 Berdyshev EV, Schmid PC, Krebsbach RJ, Schmid HH. Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells. FASEB J 2001; 15: 2171-8.
    CrossrefPubMedGoogle Scholar